ZEJULA

GlaxoSmithKline Inc🇨🇦 Health Canada

Approval Id: 3444101958adff56
Drug Approval Canada Name: ZEJULA
Product Name: ZEJULA
Status: Dormant
Status Date: 2024-10-26
Original Market Date: 2020-01-09
Din: 02489783
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XK02 NIRAPARIB
Atc Name: l 01 xk 02
Aig Number: 0161550001
Company Name: GlaxoSmithKline Inc
Company Address: 800, 100 Milverton Drive, Mississauga, Ontario, Canada, L5R 4H1
Company Detail Path: /organization/glaxosmithkline-inc

NIRAPARIB (NIRAPARIB TOSYLATE)

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3444101958adff56

Type

Standard